Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial.

Authors: R W Beck; P A Cleary; J D Trobe; D I Kaufman; M J Kupersmith; D W Paty; C H Brown
Journal: N Engl J Med Date: 1993-12-09 Impact factor: 91.245

8. Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial.

Authors: G A Chrousos; J C Kattah; R W Beck; P A Cleary
Journal: JAMA Date: 1993-04-28 Impact factor: 56.272

9. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

Authors: R W Beck; P A Cleary; M M Anderson; J L Keltner; W T Shults; D I Kaufman; E G Buckley; J J Corbett; M J Kupersmith; N R Miller
Journal: N Engl J Med Date: 1992-02-27 Impact factor: 91.245

10. Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial.

Authors: P A Cleary; R W Beck; L B Bourque; J C Backlund; P H Miskala
Journal: J Neuroophthalmol Date: 1997-03 Impact factor: 3.042

10 in total

34 in total

Review 1. Corticosteroids for treating optic neuritis.

Authors: Robin L Gal; Satyanarayana S Vedula; Roy Beck
Journal: Cochrane Database Syst Rev Date: 2015-08-14

Review 2. Current understanding of the epidemiologic and clinical characteristics of optic neuritis.

Authors: Masanori Nakazawa; Hitoshi Ishikawa; Taiji Sakamoto
Journal: Jpn J Ophthalmol Date: 2021-05-22 Impact factor: 2.447

Review 3. [Optic nerve neuritis: from an ophthalmological perspective].

Authors: H Steffen
Journal: Nervenarzt Date: 2013-12 Impact factor: 1.214

4. [Optic nerve neuritis].

Authors: H Steffen
Journal: Ophthalmologe Date: 2013-08 Impact factor: 1.059

5. Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis.

Authors: Muhammad Taimur Malik; Brian C Healy; Leslie A Benson; Pia Kivisakk; Alexander Musallam; Howard L Weiner; Tanuja Chitnis
Journal: Neurology Date: 2014-05-21 Impact factor: 9.910

6. Optic neuritis caused by the re-emerging great masquerader.

Authors: Nathanial S Nolan; Laura E Gibbons; Madihah A Hepburn; Ahmed Elkeeb; Hariharan Regunath
Journal: BMJ Case Rep Date: 2018-12-22

7. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.

Authors: John L Keltner; Chris A Johnson; Kimberly E Cello; Mariya Dontchev; Robin L Gal; Roy W Beck
Journal: Arch Ophthalmol Date: 2010-03

Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial.

1. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.

2. Recovery from severe visual loss in optic neuritis.

3. Design, methods, and conduct of the Optic Neuritis Treatment Trial.

4. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.

5. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial.

6. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group.

7. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.